Retained Earnings (Accumulated Deficit) of BELITE BIO, INC from 31 Dec 2020 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- The cumulative amount of the reporting entity's undistributed earnings or deficit.
- Summary
-
BELITE BIO, INC quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- BELITE BIO, INC Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2025 was $185,258,000, a 72% decline year-over-year.
- Source SEC data
- View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)
BELITE BIO, INC Quarterly Retained Earnings (Accumulated Deficit) (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $185,258,000 | -$77,611,000 | -72% | 31 Dec 2025 | 20-F | 31 Mar 2026 | 2025 | FY |
| Q4 2024 | $107,647,000 | -$36,144,000 | -51% | 31 Dec 2024 | 20-F | 31 Mar 2026 | 2025 | FY |
| Q4 2023 | $71,503,000 | -$31,632,000 | -79% | 31 Dec 2023 | 20-F | 17 Mar 2025 | 2024 | FY |
| Q4 2022 | $39,871,000 | -$12,648,000 | -46% | 31 Dec 2022 | 20-F | 12 Mar 2024 | 2023 | FY |
| Q4 2021 | $27,223,000 | -$9,623,000 | -55% | 31 Dec 2021 | 20-F | 31 Mar 2023 | 2022 | FY |
| Q4 2020 | $17,600,000 | 31 Dec 2020 | 20-F | 31 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.